MedTrace Logo

Quality of Life After Interventional Thyroid Treatment

NCT03880578 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 101

Last updated 2024-10-29

Study results available
· View outcomes & findings →

Summary

In this study, patients are prospectively followed after radioiodine treatment to assess the relationship between thyroid status and their quality of life after thyroid ablative treatment.

A third treatment arm after surgery has been stopped, as deemed currently not feasible to achieve its target.

Conditions

  • Thyroid; Deficiency
  • Quality of Life

Interventions

DRUG

Levothyroxine Sodium

thyroid hormone replacement

Sponsors & Collaborators

  • Klinikum Lüdenscheid

    lead OTHER

Principal Investigators

  • Rolf Larisch, Professor · Director of Department

  • Rudolf Hoermann, Professor · Klinikum Lüdenscheid

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-01
Primary Completion
2022-03-15
Completion
2022-03-15
FDA Drug
Yes

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03880578 on ClinicalTrials.gov